superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2023-12-31
- Valid until
- 2024-12-31
- Published
- 2024-01-31
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 290,403,000,000 DKK
Sources
Cite this claim
Plain text
AsOf. "Novo Nordisk revenue: 232,261,000,000 DKK", as of 2023-12-31 (until 2024-12-31). Claim clm_8ED842A2DCE7, https://asof.is/claim/clm_8ED842A2DCE7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/353278/000162828024002635/0001628280-24-002635-index.htm.
APA
AsOf. (2023). Novo Nordisk revenue: 232,261,000,000 DKK (as of 2023-12-31 (until 2024-12-31)) [Record clm_8ED842A2DCE7]. Retrieved November 9, 2026, from https://asof.is/claim/clm_8ED842A2DCE7 (source: https://www.sec.gov/Archives/edgar/data/353278/000162828024002635/0001628280-24-002635-index.htm)
BibTeX
@misc{asof_clm_8ED842A2DCE7,
author = {AsOf},
title = {Novo Nordisk revenue: 232,261,000,000 DKK},
year = {2023},
howpublished = {\url{https://asof.is/claim/clm_8ED842A2DCE7}},
note = {Claim clm\_8ED842A2DCE7, as of 2023-12-31 (until 2024-12-31); source: https://www.sec.gov/Archives/edgar/data/353278/000162828024002635/0001628280-24-002635-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_8ED842A2DCE7.md/v1/claims/clm_8ED842A2DCE7submit a correction